Revance Therapeutics Inc
Change company Symbol lookup
Select an option...
RVNC Revance Therapeutics Inc
TUSK Mammoth Energy Services Inc
MRK Merck & Co Inc
WU Western Union Co
XFLS Xfuels Inc
WAFD Washington Federal Inc
CNIKF Canada Nickel Company Inc
VMW VMware Inc
FORM FormFactor Inc
GLNG Golar LNG Ltd
Go

Health Care : Pharmaceuticals | Small Cap Growth
Company profile

Revance Therapeutics, Inc. is a commercial stage biotechnology company. The Company is focused on advanced aesthetic and therapeutic offerings, including neuromodulator product, DaxibotulinumtoxinA for Injection. The DaxibotulinumtoxinA for Injection combines a proprietary stabilizing peptide excipient with a purified botulinum toxin that does not contain human or animal-based components. The Company is also evaluating additional aesthetic and therapeutic indications for DaxibotulinumtoxinA for Injection including the full upper face, which includes glabellar lines, forehead lines and crow’s feet, and adult upper limb spasticity. It offers products and services for United States aesthetics practices, including the resilient hyaluronic acid (RHA) Collection of dermal fillers and OPUL. The RHA Collection of dermal fillers is a dermal filler for the correction of dynamic facial wrinkles and folds. OPUL’s product offering includes the point-of-sale platform, software and hardware terminal.

Closing Price
$12.24
Day's Change
-0.56 (-4.38%)
Bid
--
Ask
--
B/A Size
--
Day's High
12.90
Day's Low
12.06
Volume
(Heavy Day)
Volume:
1,302,185

10-day average volume:
1,005,376
1,302,185
  • Prev Close
    12.80
  • Today's Open
    12.65
  • Day's Range
    12.06-12.90
  • Avg Vol (10-day)
    1.0M
  • Last (time)
    4:00p ET 05/25/22
  • Last (size)
    1
  • 52-Wk Range
    11.65 - 33.83
    LowHigh
  • (07/09/21 - 02/24/22)
    5.06%
  • 79.2%
  • Market Cap
    890.7M
  • Shares Outstanding
    72.8M
  • -4.04
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 1.1
  • 82.43
  • (% of float 04/29/22)
    9.28

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.